Tidepool Earns ISO 13485 for Open Source QMS Tidepool, a nonprofit organization focused on advancing diabetes care through open-source innovation, has achieved ISO 13485:2016 certification for its open-source Quality Management…
Adagio Medical’s vCLAS Cryoablation System Earns FDA Breakthrough Status Adagio Medical Holdings, Inc. (Nasdaq: ADGM), a pioneer in catheter-based technologies for treating cardiac arrhythmias, has announced that its vCLAS™ Cryoablation…
Bruker Acquires Majority Stake in RECIPE for Drug Monitoring Assays Bruker Corporation (NASDAQ: BRKR) has announced a strategic majority investment in RECIPE Chemicals + Instruments GmbH, a well-established provider of…
ZAP Surgical to Unveil ZAP-X® Radiosurgery Platform at ESTRO 2025 ZAP Surgical Systems, Inc., a global leader in non-invasive brain surgery technology, has announced its first-time participation at the 2025…
Edwards SAPIEN M3 Gets CE Mark as First Transfemoral TMVR System Edwards Lifesciences Corporation (NYSE: EW) has announced that its groundbreaking SAPIEN M3 mitral valve replacement system has received CE…
Vicarious Surgical Inc. a next-generation robotics technology company, announced that it received a notice from the New York Stock Exchange (NYSE) on April 10, 2025, regarding non-compliance with continued listing…
Transforming Healthcare with Quake’s Real-Time UHF RFID Optimization for Patients, Pathology, Blood Banks, Pharmaceuticals, and Hospital Logistics Quake Global Unveils QIAM: A Fully Integrated AI-Powered RFID Solution for Epic EMR…
Viz.ai Wins 2025 Edison Award™ for Machine Learning Innovation for Third Year Viz.ai, a leader in artificial intelligence (AI)-powered disease detection and intelligent care coordination, has announced its recognition as…
Anaconda Biomed Enrolls First U.S. Patient in ATHENA Trial for ANA Funnel Catheter Anaconda Biomed, S.L., a company focused on developing advanced neuro thrombectomy devices, has announced the enrollment and…
Surmodics Launches Pounce™ XL Thrombectomy System for Rapid Clot Removal Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical devices and in vitro diagnostic technologies, has officially announced the commercial…
Positive Phase 2 Alzheimer’s Study Data Published, Met Primary and Secondary Endpoints Sinaptica Therapeutics, Inc., a clinical-stage company pioneering personalized neuromodulation therapies for Alzheimer’s and other neurodegenerative diseases, has announced…
Geneoscopy Appoints Amit Bhalla as CFO to Drive Growth and Commercialization Geneoscopy, Inc., a life sciences company focused on advancing gastrointestinal health through innovative diagnostic tests, has announced the appointment…